PL3152576T3 - Zastosowanie tm9sf4 jako biomarkera egzosomów powiązanych z nowotworem - Google Patents

Zastosowanie tm9sf4 jako biomarkera egzosomów powiązanych z nowotworem

Info

Publication number
PL3152576T3
PL3152576T3 PL15726199T PL15726199T PL3152576T3 PL 3152576 T3 PL3152576 T3 PL 3152576T3 PL 15726199 T PL15726199 T PL 15726199T PL 15726199 T PL15726199 T PL 15726199T PL 3152576 T3 PL3152576 T3 PL 3152576T3
Authority
PL
Poland
Prior art keywords
tm9sf4
biomarker
tumor associated
associated exosomes
exosomes
Prior art date
Application number
PL15726199T
Other languages
English (en)
Inventor
Francesco Lozupone
Antonio CHIESI
Paolo GUAZZI
Natasa ZAROVNI
Pietro Ferruzzi
Davide ZOCCO
Original Assignee
Exosomics Siena S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Exosomics Siena S.P.A. filed Critical Exosomics Siena S.P.A.
Publication of PL3152576T3 publication Critical patent/PL3152576T3/pl

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57492Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds localized on the membrane of tumor or cancer cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/56Staging of a disease; Further complications associated with the disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PL15726199T 2014-06-06 2015-06-05 Zastosowanie tm9sf4 jako biomarkera egzosomów powiązanych z nowotworem PL3152576T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14171464 2014-06-06
PCT/EP2015/062594 WO2015185730A2 (en) 2014-06-06 2015-06-05 Exosomal biomarkers
EP15726199.1A EP3152576B1 (en) 2014-06-06 2015-06-05 Use of tm9sf4 as a biomarker for tumor associated exosomes

Publications (1)

Publication Number Publication Date
PL3152576T3 true PL3152576T3 (pl) 2019-01-31

Family

ID=50896184

Family Applications (1)

Application Number Title Priority Date Filing Date
PL15726199T PL3152576T3 (pl) 2014-06-06 2015-06-05 Zastosowanie tm9sf4 jako biomarkera egzosomów powiązanych z nowotworem

Country Status (11)

Country Link
US (2) US20170146543A1 (pl)
EP (1) EP3152576B1 (pl)
JP (1) JP6650929B2 (pl)
CN (2) CN106574928A (pl)
AU (1) AU2015270450B2 (pl)
CA (1) CA2950977C (pl)
ES (1) ES2700404T3 (pl)
MX (1) MX2016016122A (pl)
PL (1) PL3152576T3 (pl)
RU (1) RU2712223C2 (pl)
WO (1) WO2015185730A2 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11614388B2 (en) 2016-10-13 2023-03-28 H.U. Group Research Institute G.K. Method for recovering extracellular vesicles
RU2770592C2 (ru) * 2017-06-21 2022-04-18 Экзосомикс С.П.А. Способы и наборы, имеющие отношение к захвату ca-ix-позитивных экзосом
AU2018384112A1 (en) 2017-12-14 2020-05-21 Sony Corporation Communication device, communication method, and program
CA3094577A1 (en) * 2018-03-30 2019-10-03 Exosomics S.p.A. Use of hollow fibers to obtain blood or a blood derivative impoverished from blood cells and platelets derived extracellular vesicles
RU2705344C1 (ru) * 2019-03-15 2019-11-06 Ольга Алексеевна Фишер Способ скрининга рака молочной железы и предрасположенности к нему

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8617806B2 (en) * 2008-01-25 2013-12-31 Hansabiomed Ou Method to measure and characterize microvesicles in the human body fluids
US20120058492A1 (en) * 2008-01-25 2012-03-08 Hansabiomed Ou Method and a Kit To Detect Malignant Tumors and Provide a Prognosis
US20120122118A1 (en) * 2008-01-25 2012-05-17 Primm Srl Monclonal antibodies, hybridomas and methods for use
ES2587055T3 (es) * 2008-01-25 2016-10-20 Hansabiomed Ou Una nueva molécula asociada a tumores humanos metastásicos, métodos para detectar tanto el gen activado como la proteína y para interferir con la expresión génica
WO2010056337A2 (en) * 2008-11-12 2010-05-20 Caris Mpi, Inc. Methods and systems of using exosomes for determining phenotypes
AU2011316477A1 (en) * 2010-10-11 2013-05-02 Medsaic Pty Ltd Assay for disease detection
CN103197066B (zh) * 2013-03-07 2015-12-23 美国纳米材料创新有限公司 一种免疫脂质体生物芯片、其制备方法及其在生物检测中的应用

Also Published As

Publication number Publication date
ES2700404T3 (es) 2019-02-15
RU2712223C2 (ru) 2020-01-27
JP6650929B2 (ja) 2020-02-19
AU2015270450B2 (en) 2021-04-01
US20170146543A1 (en) 2017-05-25
CA2950977C (en) 2023-10-10
CN113092764A (zh) 2021-07-09
RU2016152346A (ru) 2018-07-09
MX2016016122A (es) 2017-04-27
WO2015185730A3 (en) 2016-02-18
AU2015270450A1 (en) 2017-01-05
BR112016028581A2 (pt) 2018-01-30
EP3152576B1 (en) 2018-09-12
EP3152576A2 (en) 2017-04-12
US20220349892A1 (en) 2022-11-03
JP2017518517A (ja) 2017-07-06
RU2016152346A3 (pl) 2019-03-18
WO2015185730A2 (en) 2015-12-10
CN106574928A (zh) 2017-04-19
CA2950977A1 (en) 2015-12-10

Similar Documents

Publication Publication Date Title
PT3134402T (pt) Compostos de 4-amino-imidazoquinolina
AP2017009836A0 (en) Aminopyridyloxypyrazole compounds
PL3177723T3 (pl) Aptamery do zastosowania przeciwko chorobom związanym z autoprzeciwciałem
HUE042087T2 (hu) Inhalátor
IL251778A0 (en) Novel pyrazolopyrimidine histories as nik inhibitors
GB201409044D0 (en) New compounds
HRP20181530T1 (hr) Novi sulfonilaminobenzamidni spojevi
ZA201700555B (en) Azetidinyloxyphenylpyrrolidine compounds
GB201404498D0 (en) New compounds
SG11201701076TA (en) Diagnosis of cancer
PL3152576T3 (pl) Zastosowanie tm9sf4 jako biomarkera egzosomów powiązanych z nowotworem
GB201416444D0 (en) New compounds
GB201416015D0 (en) Biomarker
AU358579S (en) Inhaler
IL249130A0 (en) Preparation of piperidine-4-carbthioamide
GB201508480D0 (en) Cancer
IL248126A0 (en) Combinations of cancer treatments
GB201420239D0 (en) Biomarker
GB201414542D0 (en) Novel therapy
GB201700900D0 (en) Sequencer
GB201411343D0 (en) Biomarker
GB201417346D0 (en) New compounds
GB201417344D0 (en) New compounds
GB201416430D0 (en) New compounds
GB201409793D0 (en) Biomarker